List Biological Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- List Biological Laboratories's estimated annual revenue is currently $11.2M per year.
- List Biological Laboratories's estimated revenue per employee is $223,200
Employee Data
- List Biological Laboratories has 50 Employees.
- List Biological Laboratories grew their employee count by -15% last year.
List Biological Laboratories's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Senior Director, Quality and Compliance | Reveal Email/Phone |
3 | Production Director, Manufacturing & Process Development | Reveal Email/Phone |
4 | Director Sales and Business Development | Reveal Email/Phone |
5 | Sr. Director, Development and Manufacturing | Reveal Email/Phone |
6 | Director, Operations & Human Resources | Reveal Email/Phone |
7 | Process Development Manager | Reveal Email/Phone |
8 | QC Laboratory Manager | Reveal Email/Phone |
9 | Senior Microbiology Manager | Reveal Email/Phone |
10 | Production Operations Manager | Reveal Email/Phone |
List Biological Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is List Biological Laboratories?
List Labs specializes in the production of native toxins, recombinant proteins, bacterial fermentation, assay development, contract manufacturing, and biotherapeutics. List Labs produces C. difficile toxin A and toxin B, shiga toxins, cholera toxin, anthrax toxins (PA, LF, and EF), pertussis toxin, diphtheria toxin, CRM197, tetanus toxin, staphylococcal enterotoxin B, botulinum toxins as well as several types of lipopolysaccharides (LPS) or endotoxin for purchase by the research community.
keywords:N/AN/A
Total Funding
50
Number of Employees
$11.2M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.4M | 51 | 34% | N/A |
#2 | $19.1M | 53 | -16% | N/A |
#3 | N/A | 55 | 57% | N/A |
#4 | $21.2M | 59 | 37% | N/A |
#5 | $9.4M | 64 | -7% | N/A |